Zilun (Dan) Hu
About Zilun (Dan) Hu
Zilun (Dan) Hu is a Principal Scientist at Bristol Myers Squibb with over 20 years of experience in the pharmaceutical industry, specializing in medicinal chemistry and drug design.
Title and Role
Zilun (Dan) Hu serves as a Principal Scientist at Bristol Myers Squibb. He has been with the company since July 2002, contributing his extensive experience in medicinal chemistry and drug synthesis. His role is based in Hopewell, New Jersey, United States, where he focuses on drug design and synthesis.
Education and Academic Background
Zilun (Dan) Hu completed his undergraduate and master's education at Sichuan University, earning both a BS and an MS. He furthered his academic career at Temple University. His strong educational foundation in organic chemistry underpins his professional work in the pharmaceutical industry.
Pharmaceutical Industry Experience
With over 20 years of experience in the pharmaceutical industry, Zilun (Dan) Hu has developed a deep expertise in medicinal chemistry. His career has been marked by significant contributions to drug discovery and process development, particularly focusing on the synthesis of new compounds. His long tenure at Bristol Myers Squibb highlights his sustained impact in his field.
Specialization in Medicinal Chemistry
Specializing in medicinal chemistry, Zilun (Dan) Hu dedicates his efforts to drug design and synthesis. His work involves the creation and refinement of new compounds, playing a crucial role in the drug discovery process. His background in organic chemistry allows him to innovate in drug synthesis, significantly advancing pharmaceutical research and development.